Sign In
Buy LLY
$1,231.58
+45.87 (+3.87%)
At Close: Aug 10, 2026
Better Dividend Stock: Pfizer or Eli Lilly?
05:55am, Wednesday, 27'th Jul 2022
Both stocks could be winners for long-term investors, but one gets the nod when it comes to dividends.
10 Best Low-Volatility Stocks to Buy Now
02:01pm, Monday, 25'th Jul 2022
The stock market is suffering a turbulent 2022 so far – and with inflation still running at a 40-year high, the Federal Reserve locked in a significant rate-hiking cycle and midterm elections just m
2 Unstoppable Stocks Set to Keep Beating the Market in 2022
12:00pm, Saturday, 23'rd Jul 2022 The Motley Fool
Their drug prospects are helping them perform better than most stocks on the market this year.
Eli Lilly (LLY) Gains As Market Dips: What You Should Know
09:45pm, Friday, 22'nd Jul 2022 Zacks Investment Research
In the latest trading session, Eli Lilly (LLY) closed at $328.75, marking a +0.56% move from the previous day.
2nd-Quarter Earnings Results Could Impact Drug Company Shares
04:58pm, Friday, 22'nd Jul 2022
The second-quarter earnings season is upon us, and the news coming out of several members of Big Pharma could potentially shake up their share prices. Beyond that, several unknowns could impact top-ti
2 Pharma Giants With Momentum That Could Carry Through 2030
03:30pm, Friday, 22'nd Jul 2022 The Motley Fool
An obese population could drive competition toward a valuable market.
Eli Lilly (LLY) Outpaces Stock Market Gains: What You Should Know
09:50pm, Thursday, 21'st Jul 2022 Zacks Investment Research
In the latest trading session, Eli Lilly (LLY) closed at $326.92, marking a +1.52% move from the previous day.
New Indication Approval For Incyte "To Usher New Growth Avenue"
05:03pm, Thursday, 21'st Jul 2022 Benzinga
JMP Securities reiterated its Market Outperform rating and increased the price target to $113 from $108 for Incyte Corporation (NASDAQ: INCY) based on multiple discounted earnings per share and re
Healthcare ETFs in Focus Ahead of Q2 Earnings
03:15pm, Thursday, 21'st Jul 2022 Zacks Investment Research
The healthcare sector has gained some momentum lately on investors' rush to safety in a volatile stock market. The sector is non-cyclical in nature, which in turn, is providing a cushion to the portfo
Healthcare ETFs in Focus Ahead of Q2 Earnings
01:14pm, Thursday, 21'st Jul 2022
The healthcare sector has gained some momentum lately on investors' rush to safety in a volatile stock market. The sector is non-cyclical in nature, which in turn, is providing a cushion to the portfo
Red-Hot Eli Lilly Stock Has Room to Run
12:00pm, Thursday, 21'st Jul 2022
Schaeffer's Investment Research was built from scratch on Bernie Schaeffer's vision of providing accessible professional-grade trading information to retail traders.
Should First Trust Value Line Dividend ETF (FVD) Be on Your Investing Radar?
10:20am, Thursday, 21'st Jul 2022 Zacks Investment Research
Style Box ETF report for FVD
7 Best Pharmaceutical Stocks to Buy Now
06:00pm, Wednesday, 20'th Jul 2022
These investments represent the best pharmaceutical stocks. Each offers incredible upside potential in the post-pandemic world.
Worried About a Recession? Check Out These 2 Passive Income Stocks
03:45pm, Tuesday, 19'th Jul 2022 The Motley Fool
Specializing in niche commercial property means it's possible to stay relevant regardless of the economy.
Accenture And 3 Other Stocks Insiders Are Selling
11:51am, Tuesday, 19'th Jul 2022 Benzinga
Johnson & Johnson (NYSE: JNJ) reported upbeat earnings for its second quarter, but lowered its FY22 guidance. Investors, meanwhile, focused on some notable insider trades.
When insiders sell shares, i
